Daniel Grande is senior investigator and director of orthopaedic research at the Feinstein Institute for Medical research. He is also full professor at the newly accredited Hofstra School of Medicine. He completed his PhD at New York University and his post-doctoral fellowship in biomechanics at the Hospital for Special Surgery. He has worked extensively in the area of regenerative medicine and tissue engineering. His early work developed the first use of cell based therapy for cartilage repair, currently known as autologus chondrocyte transplantation. He has served on committees with the Orthopaedic Research Society as spine topic chair and the basic science committee.
Dr. Grande is significantly involved in mentoring and teaching of orthopaedic residents for his department. He has been a reviewer for a number of journals including: Journal of Orthopaedic Research, Clinical Orthopaedics, Osteoarthritis and Cartilage, American Journal of Sports Medicine, Nature Reviews Rheumatology and Applied Biomaterials. He has been awarded eight patents and helped found two companies in the orthopaedic surgery field of use. He has served as a member of several companies scientific advisory boards. He completed a five year rotation with OREF to assist in grant reviews. He also regularly serves on NIH study sections for RO1, R21, and SBIR/STTR grants specific to musculoskeletal applications. Daniel Grande is currently the president of the ICRS.